Hindustan Bio Sciences Ltd

HINDBIO Share Price

BSE

₹7.614.88% (-0.39)

Health Care

Biotechnology

Smallcap

With a market cap of ₹7 cr, stock is ranked 4,995

High Risk

Stock is 4.83x as volatile as Nifty

HINDBIO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care

Biotechnology

Smallcap

With a market cap of ₹7 cr, stock is ranked 4,995

High Risk

Stock is 4.83x as volatile as Nifty

HINDBIO Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
48.76	8.67	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
36.86	5.82	0.58%

HINDBIO Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

HINDBIO Company Profile

Hindustan Bio Sciences is engaged in biotechnology products business.

HINDBIO Similar Stocks (Peers)

Compare with peers Compare with peers

HINDBIO Similar Stocks (Peers)

Compare with peers Compare with peers

Biocon Ltd

BIOCON

PE Ratio

62.29

1Y Return

25.00%

Buy Reco %

86.67

Anthem Biosciences Ltd

ANTHEM

PE Ratio

87.29

1Y Return

3.98%

Buy Reco %

100.00

Sai Life Sciences Ltd

SAILIFE

PE Ratio

124.26

1Y Return

42.53%

Buy Reco %

100.00

Acutaas Chemicals Ltd

ACUTAAS

PE Ratio

111.36

1Y Return

94.49%

Buy Reco %

100.00

Onesource Specialty Pharma Ltd

ONESOURCE

PE Ratio

-859.53

1Y Return

4.92%

Buy Reco %

100.00

Compare with Peers

HINDBIO Forecast

HINDBIO Forecasts

HINDBIO

Income

Balance Sheet

Cash Flow

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	1.01	1.12	3.56	1.94	1.03	0.43	0.92	1.05	0.81	1.14
Raw Materials	0.73	0.65	2.92	1.53	0.34	0.24	0.57	0.64	0.49	0.97
Power & Fuel Cost	0.00	0.00	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Employee Cost	0.21	0.16	0.16	0.20	0.19	0.18	0.18	0.09	0.07
Selling & Administrative Expenses	0.33	0.29	0.36	0.22	0.25	0.22	0.20	0.16	0.12
Operating & Other expenses	0.21	2.28	-0.02	-0.15	1.18	0.30	0.00	0.10	0.03
EBITDA	-0.47	-2.26	0.13	0.13	-0.94	-0.51	-0.03	0.06	0.10	0.17
Depreciation/Amortization	0.01	0.01	0.01	0.01	0.01	0.00	0.01	0.01	0.00	0.01
PBIT	-0.48	-2.27	0.12	0.12	-0.95	-0.51	-0.04	0.05	0.10	0.16
Interest & Other Items	0.01	0.00	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00
PBT	-0.49	-2.27	0.11	0.11	-0.96	-0.51	-0.04	0.05	0.10	0.16
Taxes & Other Items	0.00	0.00	0.00	0.04	-0.02	0.00	0.00	0.00	0.00	0.00
Net Income	-0.49	-2.27	0.11	0.07	-0.94	-0.51	-0.04	0.05	0.10	0.16
EPS	-0.48	-2.21	0.11	0.07	-0.92	-0.50	-0.07	0.08	0.10	0.16
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

HINDBIO Income Statement

Quarter		sep 2023		dec 2023		mar 2024		jun 2024		sep 2024	dec 2024	mar 2025	jun 2025	sep 2025	dec 2025
Total Revenue	0.33	0.34	0.39	0.43	0.43	0.00	0.39	0.34	0.01	0.40
Operating & Other expenses	0.26	0.27	0.34	0.34	0.34	0.04	0.28	0.32	0.06	0.31
EBITDA	0.07	0.07	0.05	0.09	0.09	-0.04	0.11	0.02	-0.05	0.09
Depreciation/Amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
PBIT	0.07	0.07	0.05	0.09	0.09	-0.04	0.11	0.02	-0.05	0.08
Interest & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBT	0.07	0.07	0.05	0.09	0.09	-0.04	0.11	0.02	-0.05	0.08
Taxes & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	0.07	0.07	0.05	0.09	0.09	-0.04	0.11	0.02	-0.05	0.08
EPS	0.06	0.07	0.04	0.08	0.08	-0.04	0.11	0.01	-0.06	0.08

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	0.46	-0.16	-0.23	-1.32	0.82	0.75	-0.34	-0.05	-1.41	0.03
Cash from Investing Activities	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activities	-0.63	0.18	0.21	1.50	-0.81	-0.93	0.34	0.05	1.43	-0.05
Net Change in Cash	-0.17	+0.02	-0.02	+0.17	+0.01	-0.18	+0.00	+0.00	+0.02	-0.02
Changes in Working Capital	+0.59	+0.30	+2.03	-1.44	+0.69	+1.67	-0.05	-0.02	-1.46	-0.07
Capital Expenditures	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Free Cash Flow	0.46	-0.16	-0.23	-1.33	0.82	0.75	-0.34	-0.05	-1.41	0.03

HINDBIO Company Updates

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

HINDBIO Stock Peers

HINDBIO Past Performance & Peer Comparison

Comparing 3 stocks from
Health CareBiotechnology

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Hindustan Bio Sciences Ltd	78.01	8.67	—
Biocon Ltd	62.29	2.28	0.10%
Anthem Biosciences Ltd	87.29	16.35	—
Sai Life Sciences Ltd	124.26	9.93	—

HINDBIO Stock Price Comparison

Compare HINDBIO with any stock or ETF

HINDBIO

HINDBIO Holdings

HINDBIO Shareholdings

HINDBIO Promoter Holdings Trend

HINDBIO Institutional Holdings Trend

HINDBIO Shareholding Pattern

HINDBIO Shareholding History

Foreign Institutions

HINDBIO Insider Trades & Bulk Stock Deals

smallcases containing HINDBIO stock

Looks like this stock is not in any smallcase yet.

HINDBIO Events

HINDBIO Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

HINDBIO Dividend Trend

HINDBIO Dividends

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming corporate actions are available

Capital Reduction

Ex DateEx DateMar 3, 2023

- | Ratio: 1:1

Ratio

1:1

Ex DateEx Date

Mar 3, 2023

No upcoming announcements are available

Company Update

Announced OnFeb 2, 2026

Hindustan Bio Sciences Ltd - 532041 - An

Hindustan Bio Sciences Ltd - 532041 - An Download

Link

Download

Announced On

Feb 2, 2026

Result

Announced OnJan 31, 2026

Hindustan Bio Sciences Ltd - 532041 - Un

Hindustan Bio Sciences Ltd - 532041 - Un Download

Link

Download

Announced On

Jan 31, 2026

Board Meeting

Announced OnJan 31, 2026

Hindustan Bio Sciences Ltd - 532041 - Bo

Hindustan Bio Sciences Ltd - 532041 - Bo Download

Link

Download

Announced On

Jan 31, 2026

Insider Trading / SAST

Announced OnJan 24, 2026

Hindustan Bio Sciences Ltd - 532041 - Re

Hindustan Bio Sciences Ltd - 532041 - Re Download

Link

Download

Announced On

Jan 24, 2026

Company Update

Announced OnJan 23, 2026

Hindustan Bio Sciences Ltd - 532041 - An

Hindustan Bio Sciences Ltd - 532041 - An Download

Link

Download

Announced On

Jan 23, 2026

HINDBIO Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

HINDBIO Stock News & Opinions

Earnings

Hindustan Bio Sciences reports standalone net profit of Rs 0.08 crore in the December 2025 quarter

Net profit of Hindustan Bio Sciences reported to Rs 0.08 crore in the quarter ended December 2025 as against net loss of Rs 0.04 crore during the previous quarter ended December 2024. Sales reported to Rs 0.38 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.380 0 OPM %18.420 - PBDT0.09-0.04 LP PBT0.08-0.04 LP NP0.08-0.04 LP Powered by Capital Market - Live

3 weeks agoCapital Market - Live

Corporate

Hindustan Bio Sciences to convene board meeting

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 31 January 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

Hindustan Bio Sciences reports standalone net loss of Rs 0.06 crore in the September 2025 quarter

Net loss of Hindustan Bio Sciences reported to Rs 0.06 crore in the quarter ended September 2025 as against net profit of Rs 0.08 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 as against Rs 0.41 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales00.41 -100 OPM %017.07 - PBDT-0.060.08 PL PBT-0.060.08 PL NP-0.060.08 PL Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Hindustan Bio Sciences schedules board meeting

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 31 October 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Hindustan Bio Sciences to convene AGM

Hindustan Bio Sciences announced that the 33th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Earnings

Hindustan Bio Sciences standalone net profit declines 87.50% in the June 2025 quarter

Net profit of Hindustan Bio Sciences declined 87.50% to Rs 0.01 crore in the quarter ended June 2025 as against Rs 0.08 crore during the previous quarter ended June 2024. Sales declined 21.95% to Rs 0.32 crore in the quarter ended June 2025 as against Rs 0.41 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales0.320.41 -22 OPM %017.07 - PBDT0.010.08 -88 PBT0.010.08 -88 NP0.010.08 -88 Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

Hindustan Bio Sciences to announce Quarterly Result

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 31 July 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Earnings

Hindustan Bio Sciences standalone net profit rises 175.00% in the March 2025 quarter

Net profit of Hindustan Bio Sciences rose 175.00% to Rs 0.11 crore in the quarter ended March 2025 as against Rs 0.04 crore during the previous quarter ended March 2024. Sales declined 2.56% to Rs 0.38 crore in the quarter ended March 2025 as against Rs 0.39 crore during the previous quarter ended March 2024. For the full year,net profit rose 66.67% to Rs 0.10 crore in the year ended March 2025 as against Rs 0.06 crore during the previous year ended March 2024. Sales declined 21.36% to Rs 0.81 crore in the year ended March 2025 as against Rs 1.03 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales0.380.39 -3 0.811.03 -21 OPM %26.3210.26 -12.354.85 - PBDT0.110.04 175 0.100.07 43 PBT0.110.04 175 0.100.06 67 NP0.110.04 175 0.100.06 67 Powered by Capital Market - Live

8 months agoCapital Market - Live

Corporate

Hindustan Bio Sciences to announce Quarterly Result

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live

Corporate

Hindustan Bio Sciences announces board meeting date

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 23 April 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

What is the share price of Hindustan Bio Sciences Ltd (HINDBIO) today?
The share price of HINDBIO as on 27th February 2026 is ₹7.61. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Hindustan Bio Sciences Ltd (HINDBIO) share?
The past returns of Hindustan Bio Sciences Ltd (HINDBIO) share are
- Past 1 week: 0.53%
- Past 1 month: 30.09%
- Past 3 months: 20.79%
- Past 6 months: -9.08%
- Past 1 year: -5.70%
- Past 3 years: 49.51%
- Past 5 years: 178.75%
What are the peers or stocks similar to Hindustan Bio Sciences Ltd (HINDBIO)?
The peers or stocks similar to Hindustan Bio Sciences Ltd (HINDBIO) include:
What is the market cap of Hindustan Bio Sciences Ltd (HINDBIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Hindustan Bio Sciences Ltd (HINDBIO) is ₹7.80 Cr as of 27th February 2026.
What is the 52 week high and low of Hindustan Bio Sciences Ltd (HINDBIO) share?
The 52-week high of Hindustan Bio Sciences Ltd (HINDBIO) is ₹10.32 and the 52-week low is ₹5.
What is the PE and PB ratio of Hindustan Bio Sciences Ltd (HINDBIO) stock?
The P/E (price-to-earnings) ratio of Hindustan Bio Sciences Ltd (HINDBIO) is 78.01. The P/B (price-to-book) ratio is 8.67.
Which sector does Hindustan Bio Sciences Ltd (HINDBIO) belong to?
Hindustan Bio Sciences Ltd (HINDBIO) belongs to the Health Care sector & Biotechnology sub-sector.
How to buy Hindustan Bio Sciences Ltd (HINDBIO) shares?
You can directly buy Hindustan Bio Sciences Ltd (HINDBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Hindustan Bio Sciences Ltd	57.65%	40.21	Pro
Biocon Ltd	28.10%	71.51
Anthem Biosciences Ltd	32.95%	62.97
Sai Life Sciences Ltd	39.52%	69.28

Hindustan Bio Sciences Ltd

HINDBIO Share Price

HINDBIO Stock Scorecard

HINDBIO Performance & Key Metrics

HINDBIO Performance & Key Metrics

HINDBIO Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

HINDBIO Company Profile

HINDBIO Similar Stocks (Peers)

HINDBIO Similar Stocks (Peers)

HINDBIO Forecast

HINDBIO Forecasts

HINDBIO